PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHypercholesterolemia
MeSH D006937 - hypercholesterolemia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006949:Hyperlipidemias
$
Success rate
D006937: 
Hypercholesterolemia
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Salix PharmaceuticalsFenofibrate Fenoglide 2024-10-01 2007-08-10   
TevaAtorvastatin Atorvastatin  2012-05-29   
Ezetimibe Ezetimibe  2017-06-12   
Fluvastatin Fluvastatin  2012-06-12   
Lovastatin Lovastatin  2001-12-17   
Niacin Niacin  1982-01-01   
Rosuvastatin Rosuvastatin  2016-07-19   
Simvastatin Simvastatin  2006-06-23   
Aurobindo PharmaPravastatin Pravastatin  2006-04-24   
Ezetimibe Ezetimibe  2017-08-25   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2020-12-17   
Fenofibrate Fenofibrate  2016-05-05   
Niacin Niacin  2018-02-01   
Pitavastatin Pitavastatin  2016-12-20   
Rosuvastatin Rosuvastatin  2016-07-19   
Simvastatin Simvastatin  2006-12-20   
Lovastatin Lovastatin  2001-12-17   
Atorvastatin Atorvastatin  2024-02-13   
Novast LaboratoriesFenofibrate Fenofibrate  2019-04-19   
Glenmark PharmaceuticalsColesevelam Colesevelam  2018-07-16   
Ezetimibe Ezetimibe  2015-06-26   
Ezetimibe, Simvastatin Ezetimibe Simvastatin  2019-06-27   
Fenofibrate Fenofibrate  2017-04-07   
Pravastatin Pravastatin  2007-05-11   
Rosuvastatin Rosuvastatin  2016-07-19   
MylanAtorvastatin, Amlodipine besylate Amlodipine Besylate Atorvastatin  2013-11-29   
Atorvastatin Atorvastatin  2012-05-29   
Fenofibrate Fenofibrate  2005-12-29   
Fluvastatin Fluvastatin  2012-04-11   
Pitavastatin Pitavastatin  2019-04-04   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2010-06-08   
PerrigoAtorvastatin Atorvastatin  2020-06-23   
RocheFolic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine Berocca Pn  1985-10-10   
CiplaAtorvastatin Atorvastatin  2017-01-09   
Colesevelam Colesevelam  2020-04-20   
Fenofibrate Fenofibrate  2017-03-28   
Pravastatin Pravastatin  2006-10-23   
Simvastatin Simvastatin  2017-11-13   
1
2
3
4
5
6
...
13
>
Clinical Trials
Historical Success Rate
Phase 1
65%
17/26
Phase 2
59%
26/44
Phase 3
68%
50/73
Approved: 30Overall Success rate: 26%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Mylan
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use